Literature DB >> 24747702

TACTILE becomes tangible: CD96 discloses its inhibitory peculiarities.

Günter Bernhardt1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24747702     DOI: 10.1038/ni.2855

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  16 in total

1.  Physical and functional association of LFA-1 with DNAM-1 adhesion molecule.

Authors:  K Shibuya; L L Lanier; J H Phillips; H D Ochs; K Shimizu; E Nakayama; H Nakauchi; A Shibuya
Journal:  Immunity       Date:  1999-11       Impact factor: 31.745

2.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

3.  Vstm3 is a member of the CD28 family and an important modulator of T-cell function.

Authors:  Steven D Levin; David W Taft; Cameron S Brandt; Christoph Bucher; Edward D Howard; Eric M Chadwick; Janet Johnston; Angela Hammond; Kristen Bontadelli; Daniel Ardourel; LuAnn Hebb; Anitra Wolf; Thomas R Bukowski; Mark W Rixon; Joseph L Kuijper; Craig D Ostrander; James W West; Janine Bilsborough; Brian Fox; Zeren Gao; Wenfeng Xu; Fred Ramsdell; Bruce R Blazar; Katherine E Lewis
Journal:  Eur J Immunol       Date:  2011-03-18       Impact factor: 5.532

4.  Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.

Authors:  Nicole Joller; Jason P Hafler; Boel Brynedal; Nasim Kassam; Silvia Spoerl; Steven D Levin; Arlene H Sharpe; Vijay K Kuchroo
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

5.  Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts.

Authors:  Toshiyuki Oda; Seii Ohka; Akio Nomoto
Journal:  Biochem Biophys Res Commun       Date:  2004-07-09       Impact factor: 3.575

6.  Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.

Authors:  Noa Stanietsky; Tihana Lenac Rovis; Ariella Glasner; Einat Seidel; Pinchas Tsukerman; Rachel Yamin; Jonatan Enk; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-07-04       Impact factor: 5.532

7.  Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.

Authors:  M Gramatzki; W D Ludwig; R Burger; P Moos; P Rohwer; C Grünert; A Sendler; J R Kalden; R Andreesen; F Henschke; G Moldenhauer
Journal:  Exp Hematol       Date:  1998-12       Impact factor: 3.084

8.  The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1.

Authors:  S Seth; M K Maier; Q Qiu; I Ravens; E Kremmer; R Förster; G Bernhardt
Journal:  Biochem Biophys Res Commun       Date:  2007-10-29       Impact factor: 3.575

9.  The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.

Authors:  Xin Yu; Kristin Harden; Lino C Gonzalez; Michelle Francesco; Eugene Chiang; Bryan Irving; Irene Tom; Sinisa Ivelja; Canio J Refino; Hilary Clark; Dan Eaton; Jane L Grogan
Journal:  Nat Immunol       Date:  2008-11-16       Impact factor: 25.606

10.  The poliovirus receptor protein is produced both as membrane-bound and secreted forms.

Authors:  S Koike; H Horie; I Ise; A Okitsu; M Yoshida; N Iizuka; K Takeuchi; T Takegami; A Nomoto
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  12 in total

Review 1.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 2.  Monocyte trafficking across the vessel wall.

Authors:  Teresa Gerhardt; Klaus Ley
Journal:  Cardiovasc Res       Date:  2015-05-19       Impact factor: 10.787

Review 3.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

Review 4.  Activating and inhibitory receptors expressed on innate lymphoid cells.

Authors:  Sophie Guia; Aurore Fenis; Eric Vivier; Emilie Narni-Mancinelli
Journal:  Semin Immunopathol       Date:  2018-05-22       Impact factor: 11.759

Review 5.  The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease.

Authors:  Sandeep Kumar; Nicholas D Leigh; Xuefang Cao
Journal:  Front Immunol       Date:  2018-12-21       Impact factor: 7.561

Review 6.  The immune landscape of common CNS malignancies: implications for immunotherapy.

Authors:  Martina Ott; Robert M Prins; Amy B Heimberger
Journal:  Nat Rev Clin Oncol       Date:  2021-06-11       Impact factor: 66.675

7.  Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction.

Authors:  Rémi Bunet; Manon Nayrac; Hardik Ramani; Mohamed Sylla; Madeleine Durand; Carl Chartrand-Lefebvre; Jean-Pierre Routy; Alan L Landay; Jean-Francois Gauchat; Nicolas Chomont; Petronela Ancuta; Daniel E Kaufmann; Nicole Bernard; Cécile L Tremblay; Mohamed El-Far
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 8.786

8.  The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation.

Authors:  Anna K Kraus; Jin Chen; Ilka Edenhofer; Inga Ravens; Ariana Gaspert; Pietro E Cippà; Steffen Mueller; Rudolf P Wuthrich; Stephan Segerer; Guenter Bernhardt; Thomas Fehr
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

9.  Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer.

Authors:  Yun-Peng Peng; Chun-Hua Xi; Yi Zhu; Ling-Di Yin; Ji-Shu Wei; Jing-Jing Zhang; Xin-Chun Liu; Song Guo; Yue Fu; Yi Miao
Journal:  Oncotarget       Date:  2016-10-11

Review 10.  Coming of Age: CD96 Emerges as Modulator of Immune Responses.

Authors:  Hristo Georgiev; Inga Ravens; Georgia Papadogianni; Günter Bernhardt
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.